MILLICENT OSAMBA: Open Payments
NPI 1205599404 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 3 payments from 3 companies in 2025. Trend: 2023 $109 · 2024 $187 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $111 |
| Luye Pharma (USA) Ltd. | 1 | $90 |
| Amgen Inc. | 1 | $24 |
Products named: Vanrafia, ERZOFRI EXTENDED-RELEASE, TAVNEOS.
Industry payments across TX — which companies pay providers there.
